调强放疗治疗鼻咽癌临床效果及并发症  

Clinical Effect and Complications of Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma

作　　者：周运生[1] ZHOU Yun-sheng(Department of Radiotherapy,Tai'an Central Hospital,Tai'an,Shandong Province,271000 China)

机构地区：[1]泰安市中心医院放疗科,山东泰安271000

出　　处：《中外医疗》2020年第17期76-78,共3页China & Foreign Medical Treatment

摘　　要：目的分析调强放疗治疗鼻咽癌临床效果及并发症。方法随机选择2016年5月—2019年5月该院收治鼻咽癌患者100例,按随机数表分为两组,对照组50例采用常规放疗治疗,研究组50例使用调强放疗治疗,分析两组效果与并发症情况。结果研究组临床总有效94.00%比对照组78.00%高,差异有统计学意义(χ^2=5.316,P<0.05);研究组患者远期并发症发生率为12.00%,明显比对照组30.00%低,差异有统计学意义(χ^2=4.882,P<0.05);研究组患者1年生存率94.00%、2年生存率88.00%明显高于对照组,比较差异有统计学意义(χ^2=4.332、4.000,P<0.05)。结论鼻咽癌患者采用调强放疗治疗,能提升患者放疗效果,改善其预后,还能减少并发症发生,安全性高。Objective To analyze the clinical effect and complications of intensity-modulated radiotherapy for nasopharyngeal carcinoma.Methods From May 2016 to May 2019,100 patients with nasopharyngeal carcinoma were randomly selected in this hospital,and they were divided into two groups according to the random number table.The effects and complications of the two groups were analyzed.Results The total clinical effectiveness of the study group was 94.00% higher than that of the control group,78.00%,the difference was statistically significant(χ^2=5.316,P<0.05);the incidence of long-term complications in the study group was 12.00%,which was significantly lower than the control group 30.00%,the difference was statistically significant(χ^2=4.882,P<0.05);The 1-year survival rate of patients in the study group was 94.00%,and the 2-year survival rate was 88.00%,which was significantly higher than that of the control group.The difference was statistically significant(χ^2=4.332,4.000,P<0.05).Conclusion The use of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma can improve the patient's radiotherapy effect,improve its prognosis,and reduce the occurrence of complications.It has high safety.

关 键 词：调强放疗 常规放疗 鼻咽癌 临床效果 并发症 

分 类 号：R739[医药卫生—肿瘤]